Hematocrit should be checked at 36 months then annually, with testosterone dose reduction if levels exceed 54%, while testosterone levels should be monitored at 36 months after initiation or dose changes
It also emphasizes the critical need to improve the safety and efficacy of drugs through innovative drug development techniques, such as selective inhibitors, 67 dual-target inhibitors, 68,69 allosteric modulators, 70,71 covalent inhibitors, 72 proteolysis-targeting chimeras (PROTACs) 73 and protein-protein interaction (PPI) modulators, 74,75 aiming for more effective clinical translation from outcomes of research
Reduced salt and low-fat alternatives also align with current market trends, offering a safe mid-term strategy
The solution is simple: write the date on the vial every time